Genes in panel
STRs in panel
Prev Next

Primary immunodeficiency or monogenic inflammatory bowel disease

Gene: CFHR3

Red List (low evidence)

CFHR3 (complement factor H related 3)
EnsemblGeneIds (GRCh38): ENSG00000116785
EnsemblGeneIds (GRCh37): ENSG00000116785
OMIM: 605336, Gene2Phenotype
CFHR3 is in 5 panels

4 reviews

Arina Puzriakova (Genomics England Curator)

The rating of this gene has been updated from Amber to Red following NHS Genomic Medicine Service approval.
Created: 29 Jul 2022, 1:47 p.m. | Last Modified: 29 Jul 2022, 1:47 p.m.
Panel Version: 2.572

Dmitrijs Rots (Children's Clinical University Hospital)

Red List (low evidence)

Not enough evidence for monogenic PID
Created: 20 Jun 2022, 10:41 a.m. | Last Modified: 20 Jun 2022, 10:41 a.m.
Panel Version: 2.555

Sophie Hambleton (Newcastle University)

I don't know

Agree belongs in aHUS panel
Created: 29 Jun 2018, 1:33 p.m.

Louise Daugherty (Genomics England Curator)

I don't know

After internal and external review, it was agreed this gene should remain Amber, the gene is Green on the atypical haemolytic uraemic syndrome panel
Created: 3 Jul 2018, 9:17 a.m.
OriginaI Metadata from IUIS classification table (February, 2018) downloaded 20180614. IUIS Genetic defect (original gene symbol in IUIS download): CFHR1-5 .PanelApp HGNC gene symbol check: CFHR3 . IUIS Disease: Factor H -related protein deficiencies . IUIS Inheritance: AR or AD .T cells: N/A, .B cells: N/A, .IUIS Other affected cells: N/A. IUIS Associated features: Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections. IUIS Major category: Complement Deficiencies. IUIS Subcategory: N/A
Created: 2 Jul 2018, 10:35 a.m.
After internal clinical review it was agreed that the phenotype is better suited to the atypical haemolytic uraemic syndrome panel
Created: 8 Jun 2018, 1:54 p.m.
For internal clinical review- Not sure if s CFHR3 sequence variants that are risk factors for the development of susceptibility to atypical Hemolytic-uremic syndrome is relevant to this panel
Created: 8 Jun 2018, 1:12 p.m.
This gene was absent from the original PanelApp PID panel dataset (review April 2018). However it was listed in external expert immunodeficiency diagnostic gene list(s) GOSH or GRID. In this combined PID panel, this gene has been rated as AMBER and needs further curational review to assess pertinence prior to v1.
Created: 20 Apr 2018, 12:25 p.m.
Original metadata supplied by GRID. GRID Gene Symbol HGNC PanelApp check: CFHR3, GRID_Gene_Symbol: CFHR3, GRID_Transcript_ENS_Community submitted: ENST00000367425, GRID_Transcript_RefSeq: NM_021023.5, GRID_Transcript_ENS_used_on_Production: ENST00000367425
Created: 17 Apr 2018, 12:12 p.m.

Details

Mode of Inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert Review Red
  • IUIS Classification December 2019
  • IUIS Classification February 2018
  • Victorian Clinical Genetics Services
  • GRID V2.0
Phenotypes
  • Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections
  • Age related macular degeneration
  • Complement Deficiencies
  • Atypical hemolytic uremic syndrome susceptibility
OMIM
605336
Clinvar variants
Variants in CFHR3
Penetrance
None
Publications
Panels with this gene

History Filter Activity

29 Jul 2022, Gel status: 1

Added New Source, Status Update

Arina Puzriakova (Genomics England Curator)

Source Expert Review Red was added to CFHR3. Rating Changed from Amber List (moderate evidence) to Red List (low evidence)

28 Feb 2020, Gel status: 2

Added New Source, Set Phenotypes, Set publications

Louise Daugherty (Genomics England Curator)

Source IUIS Classification December 2019 was added to CFHR3. Added phenotypes Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections for gene: CFHR3 Publications for gene CFHR3 were updated from to 32048120; 32086639

12 Jul 2018, Gel status: 2

Panel promoted to version 1.0

Louise Daugherty (Genomics England Curator)

2018-07-12 Louise Daugherty (Genomics England Curator) promoted panel to v1.0. Reviews were assessed, and panel was revised according to expert reviews and further in-house curation based on PanelApp guidelines. Previous panels (A- or hypo-gammaglobulinaemia, Congenital neutropaenia, Agranulocytosis, Combined B and T cell defect, Inherited complement deficiency and SCID panels) that were merged with this panel, were checked again for any changes/new reviews prior to versioning of this panel, these merged panels are now retired/made internal.

1 Jul 2018, Gel status: 2

Set penetrance

Louise Daugherty (Genomics England Curator)

Phenotypes for gene CFHR3 were set to Age related macular degeneration, Atypical hemolytic uremic syndrome susceptibility, Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections, Complement Deficiencies

27 Jun 2018, Gel status: 2

Entity classified by Genomics England curator

Louise Daugherty (Genomics England Curator)

Gene: cfhr3 has been classified as Amber List (Moderate Evidence).

26 Jun 2018, Gel status: 2

Added New Source

Louise Daugherty (Genomics England Curator)

IUIS Classification February 2018 was added to CFHR3. Panel: Primary immunodeficiency disorders

26 Jun 2018, Gel status: 2

Added New Source

Louise Daugherty (Genomics England Curator)

Victorian Clinical Genetics Services was added to CFHR3. Panel: Primary immunodeficiency disorders

20 Apr 2018, Gel status: 2

Set Phenotypes

Louise Daugherty (Genomics England Curator)

Phenotypes for CFHR3 were set to Age related macular degeneration; Atypical hemolytic uremic syndrome susceptibility

20 Apr 2018, Gel status: 2

Added New Source

Louise Daugherty (Genomics England Curator)

Expert Review Amber was added to CFHR3. Panel: Primary immunodeficiency disorders

17 Apr 2018, Gel status: 1

Set penetrance

Louise Daugherty (Genomics England Curator)

Phenotypes for gene CFHR3 were set to Age related macular degeneration, Atypical hemolytic uremic syndrome susceptibility, Atypical hemolytic uremic syndrome susceptibility

17 Apr 2018, Gel status: 1

Added New Source

Louise Daugherty (Genomics England Curator)

CFHR3 was added to Primary immunodeficiency disorders panel. Sources: GRID V2.0

17 Apr 2018, Gel status: 1

Created

Louise Daugherty (Genomics England Curator)

CFHR3 was created by Louise Daugherty